-
公开(公告)号:US20210309716A1
公开(公告)日:2021-10-07
申请号:US17250053
申请日:2019-05-15
Applicant: UCL BUSINESS LTD
Inventor: Martin PULÉ
IPC: C07K14/705 , C07K16/28 , A61K35/17 , A61K45/06
Abstract: The present invention provides a chimeric antigen receptor (CAR) comprising a CD21− binding domain, a transmembrane domain and an intracellular domain.
-
公开(公告)号:US20210301334A1
公开(公告)日:2021-09-30
申请号:US17265244
申请日:2019-08-02
Applicant: UCL Business Ltd
Inventor: Stefan HOWORKA , Yongzheng XING
IPC: C12Q1/6869 , C12Q1/6837
Abstract: A membrane-spanning nanopore is provided, the nanopore comprising: a. one or more polynucleotide strands that provide a scaffold coma) ponent; and b. a plurality of polynucleotide strands that provide a plurality of staple components; wherein each of the plurality of staple components hybridise to the scaffold component; wherein the orientation of a major portion 7 nm of at least one polynucleotide strand comprised within the scaffold component is substantially parallel to a planar surface of a membrane as well as embedded within and substantially coplanar with the membrane; wherein the nanopore defines a channel that is suitable for perforating the membrane; the channel b) having a longitudinal axis extending along the centre thereof and a minimum internal dimension perpendicular to the longitudinal axis of at least about 3 nm. A membrane comprising the nanopore, biological sensors comprising the membrane and a method for molecular sensing using the membrane are also disclosed
-
公开(公告)号:US11058687B2
公开(公告)日:2021-07-13
申请号:US16654582
申请日:2019-10-16
Applicant: FOUNDATION MEDICINE, INC. , UCL BUSINESS LTD
Inventor: Chris Hendrik Boshoff , Timothy Robert Fenton , Matthias Alexander Lechner , Philip James Stephens , Matthew J. Hawryluk , Garrett Michael Frampton , Roman Yelensky
IPC: A61K31/551 , A61K31/505 , A61P35/00 , A61K31/519 , C12Q1/70 , A61K31/506 , A61K31/454 , A61K31/52 , A61K31/404 , A61K31/4196 , A61K33/24 , A61K31/282 , A61K31/337 , A61K31/513 , A61K39/395 , A61K31/436 , A61K31/05 , A61K31/4709 , A61K31/496 , A61K31/5377 , A61K31/352 , A61N5/00 , C12Q1/6886 , A61K31/366 , A61K31/555 , A61K31/439 , A61K31/4745 , C07K16/28 , C12Q1/6883 , G01N33/571 , A61N5/10 , A61K39/00
Abstract: Methods of treating a head and neck cancer are disclosed.
-
公开(公告)号:US11045558B2
公开(公告)日:2021-06-29
申请号:US16436521
申请日:2019-06-10
Applicant: MASSACHUSETTS EYE & EAR INFIRMARY , UCL BUSINESS LTD. , The Govt. of the USA, as represented by the Secy., Dept. of Health and Human Services
Inventor: Michael A. Sandberg , Basil Pawlyk , Alan Finlay Wright , Xinhua Shu , Tiansen Li , Robin Ali
Abstract: Methods for treating a human subject who has X-linked Retinitis Pigmentosa (XLRP) or another clinically-defined ophthalmological condition due to a loss-of-function mutation in the gene encoding the retinitis pigmentosa GTPase regulator (RPGR) protein, the method comprising administering to the subject a nucleic acid comprising an adeno-associated viral vector comprising an abbreviated human RPGR cDNA.
-
公开(公告)号:US20210170046A1
公开(公告)日:2021-06-10
申请号:US16762886
申请日:2018-11-09
Applicant: UCL Business Ltd
Inventor: Dania Grant-Serroukh , Stephen Lewis Hart
Abstract: A liposome comprising a cationic lipid, a phospholipid and a peptide and optionally consisting of from 20 to 50% by molarity cholesterol, based on the total amount of lipids, for use in non-viral gene delivery systems, for example, in the formation of lipopolyplex transfection vectors for the delivery of mRNA to cells.
-
公开(公告)号:US11024100B2
公开(公告)日:2021-06-01
申请号:US16323608
申请日:2017-08-10
Applicant: UCL Business LTD
Inventor: Carole Sudre , M Jorge Cardoso , Sebastien Ourselin , Jonathan Rohrer
Abstract: An apparatus is configured for performing a computer-implemented method comprising: receiving data comprising physical measurements of a biological organ across a three-dimensional (3D) volume, the organ having a hierarchical structure of elements with multiple levels; transforming the physical measurement data into a two-dimensional (2D) data representation having first and second axes, wherein the first axis corresponds to location of an element a spatial path through the three-dimensional volume based on the hierarchical structure of the organ, and the second axis corresponds to descending successive levels through said hierarchical structure; and outputting the two-dimensional data representation to an apparatus for display.
-
公开(公告)号:US20210138238A1
公开(公告)日:2021-05-13
申请号:US16622679
申请日:2018-06-22
Applicant: GALVANI BIOELECTRONICS LIMITED , UCL BUSINESS LTD
Inventor: David Holder , Kirill ARISTOVICH , Daniel CHEW , Matteo DONEGA
Abstract: There is provided a nerve interface device including (1, 3) comprising: at least one cuff portion; and a first pair of electrodes mounted on the at least one cuff portion. The cuff portion has an assembled position in which the cuff portion forms at least part of a passageway for receiving a nerve along a cuff axis passing through the passageway. The electrodes of the first pair are spaced apart from one another in the direction of the cuff axis.
-
公开(公告)号:US11004506B2
公开(公告)日:2021-05-11
申请号:US16499698
申请日:2018-03-29
Applicant: UCL Business LTD
Inventor: Anthony Kenyon , Adnan Mehonic , Wing Ng
Abstract: A switching resistor has a low resistance state and a high resistance state. The switching resistor comprises a dielectric layer disposed between a first electrode and a second electrode. The switching resistor further comprises a textured boundary surface between the first electrode and the dielectric layer. The textured boundary surface promotes the formation of a conductive pathway in the dielectric layer between the first electrode and the second electrode.
-
公开(公告)号:US10925943B2
公开(公告)日:2021-02-23
申请号:US14391536
申请日:2013-04-11
Applicant: UCL BUSINESS LTD
Inventor: Martin Pulé , Brian Philip
IPC: A61K39/00 , G01N33/50 , A61K35/14 , C07K14/705 , C07K16/28 , A61K35/17 , C07K14/725 , C12N15/85 , A61K48/00
Abstract: The present invention provides a polypeptide having the formula: St-R1-S1-Q-S2-R2 wherein St is a stalk sequence which, when the polypeptide is expressed at the surface of a target cell, causes the R and Q epitopes to be projected from the cell surface; R1 and R2 are a Rituximab-binding epitopes each having the an amino acid sequence selected from the group consisting of SEQ ID No. 1, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15 and 16 or a variant thereof which retains Rituximab-binding activity; S1 and S2 are optional spacer sequences, which may be the same or different; and Q is a QBEnd1O-binding epitope having the amino acid sequence shown as SEQ ID No. 2 or a variant thereof which QBEnd1O-binding activity. The invention also provides a nucleic acid sequence encoding such a polypeptide and uses thereof in adoptive cell transfer.
-
公开(公告)号:US20210002648A1
公开(公告)日:2021-01-07
申请号:US16969278
申请日:2019-02-12
Applicant: UCL BUSINESS LTD
Inventor: James John Cox , Devjit Srivastava
IPC: C12N15/113
Abstract: The present invention relates to analgesic treatments to reduce pain through use of an inhibitor of fatty-acid amide hydrolase pseudogene (FAAH-OUT).
-
-
-
-
-
-
-
-
-